Benjamini O, Fried S, Shouval R, Flynn JR, Beyar-Katz O, Leslie LA, Zucherman T, Yerushalmi R, Shem-Tov N, Palomba ML, Danylesko I, Sdayoor I, Malka H, Itzhaki O, Suh H, Devlin SM, Marcus R, Dahi PB, Jacoby E, Shah GL, Sauter CS, Ip A, Perales M-A, Nagler A, Shimoni A, Scordo M, Avigdor A. Anti-CD19 chimeric antigen receptor T-cell therapy has less efficacy in Richter transformation than in <i>de novo</i&gt; large B-cell lymphoma and transformed low-grade B-cell lymphoma. Haematologica; https://doi.org/10.3324/haematol.2023.284664 [Early view].